Progressive Resistance Training Compared to Neuromuscular Exercise in Patients With Hip Osteoarthritis (HipBooster)
Primary Purpose
Hip Osteoarthritis
Status
Active
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Progressive Resistance Training and no booster sessions
Progressive Resistance Training and booster sessions
Neuromuscular exercise and no booster sessions
Neuromuscular exercise and booster sessions
Sponsored by
About this trial
This is an interventional treatment trial for Hip Osteoarthritis focused on measuring Progressive Resistance Training, Neuromuscular Exercise, Physical Therapy, Physical Rehabilitation
Eligibility Criteria
Inclusion Criteria:
- Clinically diagnosed OA of the hip joint according to the National Institute for Health and Care Excellence criteria
- Have experienced pain of at least 3 out of 10 on the visual analog scale in the index hip within the last two weeks
- Age ≥ 45 years
- No surgery in the lower extremities six months prior to inclusion
- No comorbidity that prevents exercising
- Adequacy in written and spoken Danish
- Not being a candidate for total hip arthroplasty
Exclusion Criteria:
- BMI score > 40
- Pregnancy
- Resistance training or neuromuscular training for the lower extremities for more than 12 sessions in the last 6 months or 6 sessions in the last 3 months (resistance training is defined by the American College of Sports Medicine guidelines while neuromuscular training is defined by exercises involving multiple joints and muscle groups performed in functional weight-bearing positions with emphasis on the quality and efficiency of movement, as well as alignment of the trunk and lower limb joints)
- Planned vacation for more than 14 days within the 12-week intervention period without the possibility of expanding the intervention accordingly
Sites / Locations
- Aarhus University Hospital
- Aarhus University
- Næstved-Slagelse-Ringsted Hospitals
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Active Comparator
Experimental
Arm Label
Group 1:
Group 2:
Group 3:
Group 4:
Arm Description
PRT
PRT + Booster sessions
NEMEX
NEMEX + Booster sessions
Outcomes
Primary Outcome Measures
Change in functional performance measured by the 30-seconds chair stand test
The 30-second chair stand test is a valid and responsive measure of lower-extremity muscle strength evaluating sit-to-stand function, which is limited in people with lower extremity OA.
Secondary Outcome Measures
Change in 40m fast-paced walk test
Time (in seconds) taken to complete a 40 m course at fast walking pace.
Change in 9 step stair climb test
Time (in seconds) taken to negotiate 9 steps on a standard step-height stair-way (up and down).
Change in leg extension muscle power (watt/kg bodyweight)
Leg extensor muscle power (force times acceleration) will be measured using the Nottingham Power Rig (NPR). The NPR measures the power output in total watt and watt pr. bodyweight in kilograms from a seated push on a flat pedal which is transmitted by a lever and chain to spin a flywheel. The NPR is a safe and reliable method to measure explosive knee extensor muscle power and has been validated as a clinically important measure of muscle function in elderly individuals.
Change in the HOOS pain subscale
The HOOS pain subscale is a 10-item patient-reported outcome measure designed to assess other hip symptoms in patients with hip osteoarthritis. The total score ranges from 0 to 100, with higher scores indicating better symptoms status.
Change in the HOOS activities of daily living (ADL) function subscale
The HOOS ADL function subscale is a 17-item patient-reported outcome measure designed to assess ADL function in patients with hip osteoarthritis. The total score ranges from 0 to 100, with higher scores indicating better ADL function status.
Change in the HOOS quality-of-life subscale
The HOOS quality-of-life subscale is a four-item patient-reported outcome measure designed to assess hip-related quality-of-life in patients with hip osteoarthritis. The total score ranges from 0 to 100, with higher scores indicating better quality-of-life status.
Change in the HOOS sports and recreation subscale
The HOOS sports and recreation subscale is a four-item patient-reported outcome measure designed to assess sports and recreation function in patients with hip osteoarthritis. The total score ranges from 0 to 100, with higher scores indicating better sports and recreation status.
Global Perceived Effect (GPE)
The GPE of the interventions will be assessed for three domains on a 7-point Likert scale
Change in muscle strength
Muscle strength is measured in a standardized one-repetition maximum test for the leg press exercise.
Change in the HOOS symptoms subscale
The HOOS symptoms subscale is a five-item patient-reported outcome measure designed to assess hip symptoms in patients with hip osteoarthritis. The total score ranges from 0 to 100, with higher scores indicating better symptoms status.
Adherence to the 12 week initial intervention
High adherence is defined as ≥ 80% attendance to the supervised interventions.
Adherence to the 9 months of self-administered training
High adherence is defined by ≥ 80% of the assigned exercise programs performed at home or at the fitness center.
AE (Adverse Events) & Serious Adverse Events (SAE)
Continous registration of health issues and injuries. Physiotherapists in charge of the training sessions will monitor potential AE and SAE. Also, during the follow-up visits at week 12 and 12 months, the participants will be asked about potential AE's and SAE's using open-probe questions.
Drop-outs
Number og drop-out from the training interventions.
Full Information
NCT ID
NCT04714047
First Posted
January 15, 2021
Last Updated
August 31, 2023
Sponsor
University of Aarhus
Collaborators
Vejle Hospital, Naestved Hospital, Regional Hospital Holstebro, Aarhus University Hospital, Physiotherapy Associates, Slagelse Hospital, University of Southern Denmark, Regionshospitalet Silkeborg
1. Study Identification
Unique Protocol Identification Number
NCT04714047
Brief Title
Progressive Resistance Training Compared to Neuromuscular Exercise in Patients With Hip Osteoarthritis
Acronym
HipBooster
Official Title
Progressive Resistance Training Compared to Neuromuscular Exercise in Patients With Hip Osteoarthritis, and the Additive Effect of Booster Sessions: A Multicenter Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
January 18, 2021 (Actual)
Primary Completion Date
May 1, 2024 (Anticipated)
Study Completion Date
May 1, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Aarhus
Collaborators
Vejle Hospital, Naestved Hospital, Regional Hospital Holstebro, Aarhus University Hospital, Physiotherapy Associates, Slagelse Hospital, University of Southern Denmark, Regionshospitalet Silkeborg
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The primary aim of this randomized controlled trial is to investigate the effectiveness of 12 weeks of progressive resistance training (PRT) compared to neuromuscular exercise (NEMEX) on functional performance in patients with hip OA measured by the 30-seconds chair stand test. Secondary aims are to investigate; the determinants of improvement in physical function following PRT or NEMEX; the effectiveness of booster sessions in prolonging the effects of the initial interventions (12 months), the cost-effectiveness of booster sessions (12 months). We will test the hypothesis that PRT is superior to NEMEX in improving physical function measured with the 30s sit-to-stand test at 12 week follow-up.
Detailed Description
This randomized controlled trial will be a multicenter trial involving hospitals and physiotherapy clinics across Denmark. Part 1: For the initial 12-week exercise intervention, participants will be randomized into two groups: PRT or NEMEX. Part 2: After the initial intervention, participants in each group will be randomized to booster sessions (PRT+B and NEMEX+B) or to receive no further treatment (PRT-B and NEMEX-B). Booster sessions will be provided at 4, 6, 8 and 10 months after baseline. Outcomes will be measured at baseline, after 12 weeks of intervention, and at 6-, 9- and 12-months follow-up.
The exercise interventions will be performed at the collaborating hospitals and physiotherapy clinics across Denmark. All sessions will be conducted in group sessions with one physiotherapist supervising the exercises. The duration and frequency of the interventions will be 12 weeks with 2 supervised sessions each week. If participants experience pain during exercise exceeding 5 out of 10 on a Visual Analogue Scale (VAS), the physiotherapist will modify the exercise, decreasing the exercise intensity (load) or modifying the range of motion. All unilateral exercises will be performed for both sides.
The NEMEX intervention will follow the NEMEX program as described by Ageberg et al. The sessions consist of a 10-minute submaximal warm up on an exercise bike followed by 50 minutes of NEMEX training with exercises focused on stability, postural function, postural orientation, lower extremity muscle strength, and functional exercises.
The PRT intervention will follow the same protocol for training frequency and duration as the NEMEX intervention. The sessions consist of a 10-minute submaximal warm up on an exercise bike followed by 50 minutes of PRT with exercises targeting the muscles of the hip and knee joints; leg press, hip extension, hip abduction, hip flexion and knee extension.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hip Osteoarthritis
Keywords
Progressive Resistance Training, Neuromuscular Exercise, Physical Therapy, Physical Rehabilitation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
160 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group 1:
Arm Type
Experimental
Arm Description
PRT
Arm Title
Group 2:
Arm Type
Experimental
Arm Description
PRT + Booster sessions
Arm Title
Group 3:
Arm Type
Active Comparator
Arm Description
NEMEX
Arm Title
Group 4:
Arm Type
Experimental
Arm Description
NEMEX + Booster sessions
Intervention Type
Other
Intervention Name(s)
Progressive Resistance Training and no booster sessions
Intervention Description
An initial 12-week exercise intervention, consisting of 1-hour group sessions of progressive resistance training supervised by a physiotherapist 2 times per week.
The sessions consist of a 10-minute submaximal warm up on an exercise bike followed by 50 minutes of PRT with exercises targeting the muscles of the hip and knee joints; leg press, hip extension, hip abduction, hip flexion and knee extension. The progression will be in line with guidelines provided by the American College of Sports Medicine. The intensity will follow repetition maximum (RM) targets, from 12 RM for the first week towards 8 RM for the last weeks.
After the 12 weeks, this group consists of patients who are randomized to receive no further treatment. For the following 9 months, these patients are given a membership to a fitness center where they are encouraged to continue the same exercise regime.
Intervention Type
Other
Intervention Name(s)
Progressive Resistance Training and booster sessions
Intervention Description
An initial 12-week exercise intervention, consisting of 1-hour group sessions of progressive resistance training supervised by a physiotherapist 2 times per week.
The sessions consist of a 10-minute submaximal warm up on an exercise bike followed by 50 minutes of PRT with exercises targeting the muscles of the hip and knee joints; leg press, hip extension, hip abduction, hip flexion and knee extension. The progression will be in line with guidelines provided by the American College of Sports Medicine. The intensity will follow repetition maximum (RM) targets, from 12 RM for the first week towards 8 RM for the last weeks.
After the 12 weeks, this group consists of patients who are randomized to receive 4 booster sessions (at 1, 3, 5 and 7 months after termination of the initial 12 week intervention). Additionally, for the following 9 months, these patients are given a membership to a fitness center where they are encouraged to continue the same exercise regime without supervision.
Intervention Type
Other
Intervention Name(s)
Neuromuscular exercise and no booster sessions
Intervention Description
An initial 12-week exercise intervention, consisting of 1-hour group sessions of progressive resistance training supervised by a physiotherapist 2 times per week.
The sessions consist of a 10-minute submaximal warm up on an exercise bike followed by 50 minutes of NEMEX training with exercises focused on stability, postural function, postural orientation, lower extremity muscle strength, and functional exercises. Progression is made when an exercise is performed with good sensorimotor control and good quality of the performance and with minimal exertion and adequate control of the movement.
After the 12 weeks, this group consists of patients who are randomized to receive no further treatment. For the following 9 months, these patients are given equipment and encouraged to continue the same exercise regime at home without supervision.
Intervention Type
Other
Intervention Name(s)
Neuromuscular exercise and booster sessions
Intervention Description
An initial 12-week exercise intervention, consisting of 1-hour group sessions of progressive resistance training supervised by a physiotherapist 2 times per week.
The sessions consist of a 10-minute submaximal warm up on an exercise bike followed by 50 minutes of NEMEX training with exercises focused on stability, postural function, postural orientation, lower extremity muscle strength, and functional exercises. Progression is made when an exercise is performed with good sensorimotor control and good quality of the performance and with minimal exertion and adequate control of the movement.
After the 12 weeks, this group consists of patients who are randomized to receive 4 booster sessions (at 1, 3, 5 and 7 months after termination of the initial 12 week intervention). Additionally, for the following 9 months, these patients are given equipment and encouraged to continue the same exercise regime at home.
Primary Outcome Measure Information:
Title
Change in functional performance measured by the 30-seconds chair stand test
Description
The 30-second chair stand test is a valid and responsive measure of lower-extremity muscle strength evaluating sit-to-stand function, which is limited in people with lower extremity OA.
Time Frame
Measured at baseline, 12 week and 12 month follow-up.
Secondary Outcome Measure Information:
Title
Change in 40m fast-paced walk test
Description
Time (in seconds) taken to complete a 40 m course at fast walking pace.
Time Frame
Measured at baseline, 12 week and 12 month follow-up.
Title
Change in 9 step stair climb test
Description
Time (in seconds) taken to negotiate 9 steps on a standard step-height stair-way (up and down).
Time Frame
Measured at baseline, 12 week and 12 month follow-up.
Title
Change in leg extension muscle power (watt/kg bodyweight)
Description
Leg extensor muscle power (force times acceleration) will be measured using the Nottingham Power Rig (NPR). The NPR measures the power output in total watt and watt pr. bodyweight in kilograms from a seated push on a flat pedal which is transmitted by a lever and chain to spin a flywheel. The NPR is a safe and reliable method to measure explosive knee extensor muscle power and has been validated as a clinically important measure of muscle function in elderly individuals.
Time Frame
Measured at baseline, 12 week and 12 month follow-up.
Title
Change in the HOOS pain subscale
Description
The HOOS pain subscale is a 10-item patient-reported outcome measure designed to assess other hip symptoms in patients with hip osteoarthritis. The total score ranges from 0 to 100, with higher scores indicating better symptoms status.
Time Frame
Measured at baseline, 12 week and 12 month follow-up.
Title
Change in the HOOS activities of daily living (ADL) function subscale
Description
The HOOS ADL function subscale is a 17-item patient-reported outcome measure designed to assess ADL function in patients with hip osteoarthritis. The total score ranges from 0 to 100, with higher scores indicating better ADL function status.
Time Frame
Measured at baseline, 12 week and 12 month follow-up.
Title
Change in the HOOS quality-of-life subscale
Description
The HOOS quality-of-life subscale is a four-item patient-reported outcome measure designed to assess hip-related quality-of-life in patients with hip osteoarthritis. The total score ranges from 0 to 100, with higher scores indicating better quality-of-life status.
Time Frame
Measured at baseline, 12 week and 12 month follow-up.
Title
Change in the HOOS sports and recreation subscale
Description
The HOOS sports and recreation subscale is a four-item patient-reported outcome measure designed to assess sports and recreation function in patients with hip osteoarthritis. The total score ranges from 0 to 100, with higher scores indicating better sports and recreation status.
Time Frame
Measured at baseline, 12 week and 12 month follow-up.
Title
Global Perceived Effect (GPE)
Description
The GPE of the interventions will be assessed for three domains on a 7-point Likert scale
Time Frame
Measured at 12 week and 12 month follow-up.
Title
Change in muscle strength
Description
Muscle strength is measured in a standardized one-repetition maximum test for the leg press exercise.
Time Frame
Measured at baseline, 12 week and 12 month follow-up.
Title
Change in the HOOS symptoms subscale
Description
The HOOS symptoms subscale is a five-item patient-reported outcome measure designed to assess hip symptoms in patients with hip osteoarthritis. The total score ranges from 0 to 100, with higher scores indicating better symptoms status.
Time Frame
Measured at baseline, 12 week and 12 month follow-up.
Title
Adherence to the 12 week initial intervention
Description
High adherence is defined as ≥ 80% attendance to the supervised interventions.
Time Frame
Registered throughout the 12 week initial intervention.
Title
Adherence to the 9 months of self-administered training
Description
High adherence is defined by ≥ 80% of the assigned exercise programs performed at home or at the fitness center.
Time Frame
Registered throughout the 9 months follow-up period.
Title
AE (Adverse Events) & Serious Adverse Events (SAE)
Description
Continous registration of health issues and injuries. Physiotherapists in charge of the training sessions will monitor potential AE and SAE. Also, during the follow-up visits at week 12 and 12 months, the participants will be asked about potential AE's and SAE's using open-probe questions.
Time Frame
Registered throughout the 12 month study period.
Title
Drop-outs
Description
Number og drop-out from the training interventions.
Time Frame
Registered throughout the 12 month study period.
Other Pre-specified Outcome Measures:
Title
Number of joint replacements
Description
Patient-reported joint replacements
Time Frame
Measured at baseline and 12 month follow-up.
Title
Productivity Costs Questionnaire (IPCQ)
Description
The IPCQ questionnaire includes three modules measuring productivity losses of paid work due to 1) absenteeism and 2) presenteeism and productivity losses related to 3) unpaid work
Time Frame
Measured at 12 week and 6, 9, 12 month follow-up.
Title
Physical activity level
Description
Patient reported physical activity levels is assessed with a three domain questionnaire.
Time Frame
Measured at baseline, 12 week and 12 month follow-up.
Title
Change in pain measured on a Numerical Rating Scale (NRS)
Description
NRS pain score will be measured before and after each exercise session and at each follow-up evaluation before and after completing the functional performance tests.
Time Frame
Measured at baseline, 12 week and 12 month follow-up.
Title
Healthcare Utilization Questionnaire (HUQ)
Description
The HUQ is a nine-item patient-reported outcome measure designed to assess healthcare and medicine usage.
Time Frame
Measured at baseline, 12 week and 6, 9, 12 month follow-up.
Title
Change in EuroQol Group 5-dimension 5-level (EQ-5D-5L)
Description
The EQ-5D-5L is a five-item patient-reported outcome measure designed to assess generic health-related quality-of-life. The total score of the descriptive index and EQ-VAS ranges from -0.624 (worst) to 1.000 (best) and 0 (worst imaginable health) to 100 (best imaginable health), respectively.
Time Frame
Measured at baseline, 12 week and 6, 9, 12 month follow-up.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinically diagnosed OA of the hip joint according to the National Institute for Health and Care Excellence criteria
Have experienced pain of at least 3 out of 10 on the visual analog scale in the index hip within the last two weeks
Age ≥ 45 years
No surgery in the lower extremities six months prior to inclusion
No comorbidity that prevents exercising
Adequacy in written and spoken Danish
Not being a candidate for total hip arthroplasty
Exclusion Criteria:
BMI score > 40
Pregnancy
Resistance training or neuromuscular training for the lower extremities for more than 12 sessions in the last 6 months or 6 sessions in the last 3 months (resistance training is defined by the American College of Sports Medicine guidelines while neuromuscular training is defined by exercises involving multiple joints and muscle groups performed in functional weight-bearing positions with emphasis on the quality and efficiency of movement, as well as alignment of the trunk and lower limb joints)
Planned vacation for more than 14 days within the 12-week intervention period without the possibility of expanding the intervention accordingly
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Troels Kjeldsen, MSd
Organizational Affiliation
Aarhus University Hospital and Aarhus University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Inger Mechlenburg, Prof.
Organizational Affiliation
Aarhus University Hospital and Aarhus University
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Søren T Skou, Prof.
Organizational Affiliation
Slagelse Hospital and University of Southern Denmark
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Ulrik Dalgas, Prof.
Organizational Affiliation
University of Aarhus
Official's Role
Study Director
Facility Information:
Facility Name
Aarhus University Hospital
City
Aarhus N
ZIP/Postal Code
8200
Country
Denmark
Facility Name
Aarhus University
City
Aarhus
Country
Denmark
Facility Name
Næstved-Slagelse-Ringsted Hospitals
City
Slagelse
Country
Denmark
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Anonymised patient-level data for the primary and all secondary outcome measures will be made available if required by the scientific journal, in which the results of the trial are published.
IPD Sharing Time Frame
Data will be available after publication of the trial.
IPD Sharing Access Criteria
Data access will be reviewed by the author group. Requesters will be required to sign a Data Access Agreement.
Citations:
PubMed Identifier
36109033
Citation
Kjeldsen T, Dalgas U, Skou ST, van Tulder M, Bibby BM, Mechlenburg I. Progressive resistance training compared to neuromuscular exercise in patients with hip osteoarthritis and the additive effect of exercise booster sessions: protocol for a multicentre cluster randomised controlled trial (The Hip Booster Trial). BMJ Open. 2022 Sep 15;12(9):e061053. doi: 10.1136/bmjopen-2022-061053.
Results Reference
derived
Learn more about this trial
Progressive Resistance Training Compared to Neuromuscular Exercise in Patients With Hip Osteoarthritis
We'll reach out to this number within 24 hrs